Skip to content

Zoll M Series ETCO2 Option

by Zoll Medical Corp

510(k) K993036

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)ST Traditional NumberK993036 Date28 Feb 2000DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MKJ
Device Class
Class III
Regulation
21 CFR Part 870.5310
Advisory Committee
Cardiovascular
FDA Decision
ST

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Zoll M Series ETCO₂ Option is an automated external defibrillator (non-wearable) with an integrated end-tidal carbon dioxide (ETCO₂) monitoring capability. It provides continuous, noninvasive measurement of ETCO₂ and respiration rate, enabling real-time assessment of ventilatory function and metabolic status in patients.

This device is supplied as an add-on option for the M Series monitor/defibrillator platform and is intended for use in prehospital, emergency department, and critical care settings. It is classified as a Class III medical device under FDA regulation 870.5310 and requires a Premarket Approval (PMA) pathway, though this submission was cleared under a 510(k) with tracking. The device incorporates a Capnostat® sensor and Novametrix technology for ETCO₂ monitoring, with no specific sterility or single-use designation noted in the data.

Other devices from Zoll Medical Corporation

See all devices from Zoll Medical Corporation →